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Background: Our anesthetic practice was hindered by inadequate postanesthesia care unit space resulting in
operating room inefficiencies. In response, an anesthetic protocol designed to reduce the duration of postanesthesia
stay by decreasing residual anesthetic sedation and postoperative nausea and vomiting (PONV) was introduced. Here
the impact of this practice change is analyzed.
Methods: The protocol encouraged desflurane use instead of isoflurane, triple antiemetic prophylaxis, and discouraged
midazolam. Records of patients undergoing general anesthesia from calendar-matched epochs were reviewed. Epoch I
included a 6-month period prior to implementation of the practice change (October 1, 2009, to March 31, 2010)
and Epoch II included 6 months following the practice change (October 1, 2010, to March 31, 2011).
Results: General anesthesia was administered to 2,936 and 3,137 patients during Epochs I and II, respectively.
Midazolam decreased from 57.4% to 24.0%, isoflurane from 50.8% to 5.7%, desflurane increased from 25.6% to
77.0%, and antiemetic prophylaxis from 6.5% to 50.8%. Median [IQR] recovery time decreased from 72 [50, 102] to
62 [44, 90] minutes, P <0.001. Supplemental analyses found antiemetic prophylaxis was associated with PONV reduction
(OR = 0.47, 95% CI 0.38 –0.58, P < 0.001). When compared to isoflurane, desflurane was associated with a decreased rate
of respiratory depression (OR = 0.72, 95% CI 0.55-0.93, P = 0.013). Patients administered midazolam trended towards
higher rate of respiratory depression (OR = 1.27, 95% CI 1.00–1.60, P = 0.050).
Conclusions: Introduction of an anesthetic protocol that was designed to attenuate adverse anesthetic effects was
associated with a reduction of anesthetic recovery time.
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HypoventilationBackground
Efficient surgical practices rely on interaction between
perioperative and postoperative care areas to facilitate pa-
tient throughput [1]. Postoperative care is complex and
comprised of multiple clinical areas. The lynchpin of this
system is the Postanesthesia Care Unit (PACU) where pa-
tients undergo immediate recovery from anesthesia (Phase
I recovery) prior to discharge to ambulatory settings, post-
operative wards, and advanced monitoring wards (Phase II
recovery). When patient volume surpasses PACU capacity,* Correspondence: weingarten.toby@mayo.edu
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unless otherwise stated.a bottleneck of patient flow is created delaying discharge
from the operating room [2]. Slow anesthetic emergence,
excessive respiratory depression, and postoperative nausea
and vomiting (PONV) can prolong PACU stays [2-4].
Our practice in year 2009 almost daily outstripped PACU
capacity which resulted in patient transfer delays from the
operating room to PACU. In response, a practice improve-
ment initiative for adult patients undergoing general
endotracheal anesthesia (GETA) designed to facilitate
Phase I recovery was formulated. This protocol consisted of
elements designed to reduce time to emergence from
anesthesia and occurrence of respiratory depression (redu-
cing routine midazolam administration, substituting des-
flurane for isoflurane as the primary inhalational anesthetic)ntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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laxis regardless of PONV risk). The primary hypothesis of
this study was that this practice change was associated with
faster Phase I recovery.
Methods
This study was approved by the Mayo Clinic, Rochester
MN, Institutional Review Board (ID number 13–000171,
approved February 5, 2013). Consistent with Minnesota
Statute 144.295, all patients provided authorization for
research use of their medical records.
Study design
On August 1, 2010, an anesthesia protocol designed to
hasten Phase I anesthesia recovery of patients undergoing
GETA was instituted. To assess whether recovery short-
ened, a retrospective analysis of clinical outcomes before
and after protocol implementation was performed. To
allow time for acceptance of the protocol a 2-month tran-
sition period from protocol institution to the start of data
collection was allowed. Therefore, data were obtained dur-
ing the 6 month period from October 1, 2010, through
March 31, 2011 [Epoch II]). In order to ensure that similar
calendar periods were compared pre-implementation data
were obtained from October 1, 2009, through March 31,
2010 [Epoch I].
Patient selection
Included were adult patients who underwent GETA,
transferred to the PACU, and extubated prior to PACU
discharge. Patients were excluded if they bypassed the
PACU; had surgery when PACU staffing was not stand-
ard (i.e., weekends); or had surgery performed under
monitored anesthesia care or regional anesthesia.
Study setting
This study was of the practice of a single anesthesia div-
ision within a large anesthesia department. This division
provided care for 27 operating rooms which typically
serve general, urological, plastic, otolaryngologic, and
ophthalmologic specialties as well as endoscopic proce-
dures too complex to be performed in the gastrointes-




The anesthesia practice was conducted according to the
attending anesthesiologist’s discretion, but typically con-
sisted of an intravenous induction with midazolam, fen-
tanyl, and propofol; maintenance with isoflurane; and
antiemetic prophylaxis with ondansetron with or with-
out dexamethasone.Practice improvement protocol
The anesthesia protocol consisted of three practice changes.
Two were designed to hasten anesthetic recovery (midazo-
lam was no longer routinely used with induction and
desflurane became the default volatile anesthetic) while
the third change was aimed to reduce PONV (by using
0.625 mg droperidol, and 4 mg of dexamethasone at
the beginning of anesthesia, and 4 mg of ondansetron
at the end of anesthesia). Because of the heterogeneity
of this practice, there were no recommendations re-
garding the analgesic regimen. Compliance was not
mandatory and anesthesiologists could deviate for indi-
vidual circumstances.PACU clinical practice
The PACU in the clinical practice serves this division as
well as other clinical areas (i.e., thoracic, vascular, ortho-
pedic, spine, neurosurgery, and radiology performed
under general anesthesia). The PACU does not accept
pediatric outpatients nor does it serve as an overflow for
the intensive care unit. The PACU is staffed by regis-
tered nurses as well as an anesthesia resident. The at-
tending anesthesiologist was also immediately available.
Discharge criteria for Phase I recovery were primarily
based on standard discharge criteria, goal pain scores
and control of postoperative nausea, as well as for re-
spiratory depression as defined by four respiratory spe-
cific events, see Table 1 [5-8].Data abstraction
Electronic medical records were abstracted using propri-
etary software [9,10]. Presurgical variables included pa-
tient age, sex, body mass index, and American Society of
Anesthesiologist Physical Status. Perioperative variables
included procedure type; surgical duration; medications;
use of regional technique for postoperative analgesia;
and Phase I recovery course including duration, medica-
tions, and respiratory depression [7,8].
Perioperative dysrhythmia was defined as the use of anti-
arrhythmic agent or cardioversion, hypertension by the ad-
ministration of antihypertensive agents, and bronchospasm
by albuterol administration. Intraoperative hypotension was
assessed from the records of administration of epinephrine,
dopamine, calcium chloride, vasopressin, or phenylephrine
infusion. Hypotension during Phase I recovery was assessed
from the administration of ephedrine or phenylephrine.
Antiemetic prophylaxis was determined from the adminis-
tration of droperidol, dexamethasone, ondansetron or gran-
isetron. PONV was identified from the use of rescue
antiemetic medication in the PACU. Perioperative opioids
were converted to intravenous morphine equivalents using
published guidelines [11,12]. The ultrashort acting remifen-
tanil was not included in morphine equivalent calculations.





Motor activity No motion Weak motion Active motion
Respiration Required airway maintenance Maintains airway without support Coughs on command
Blood pressure Systolic blood pressure ≥ ± 50 mmHg
preanesthetic value
Systolic blood pressure ± 20–50 mmHg
preanesthetic value
Systolic blood pressure ± 20 mmHg
preanesthetic value
Consciousness No response or absent protective
reflexes
Responds to stimulus Fully awake or easily aroused
Oxyhemoglobin
saturation
<93% or preoperative value with
supplemental oxygen
≥93% or preoperative value with
supplemental oxygen
≥93% or preoperative value without
supplemental oxygen
Respiratory Specific Events [7,8]†
Hypoventilation 3 episodes of < 8 respirations/minute
Apnea Episode of apnea ≥ 10 seconds
Hypoxemia 3 episodes of oxyhemoglobin desaturations as measured by pulse oximetry (<90% with or without nasal cannula)
Pain/sedation
mismatch
Richmond Agitation Sedation Score[6] = −3 to −5 and a numeric pain score > 5, from a scale 0 to 10
Additional Discharge Criteria
Numeric Pain Score Score ≤ 4
Postoperative nausea Mild to none
*To meet discharge criteria the composite score needs to be ≥ 8 with absence of 0 score in any of the 5 subcategories †Any patient who develops a respiratory specific
event must have a subsequent 60-minute period free of further events in order to be transferred to a nonmonitored ward. Patients who had repeated respiratory specific
events are discharged to an advanced monitored setting or continuously monitored for oxyhemoglobin desaturation via pulse oximetry.
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time of PACU admission to the time that Phase I dis-
charge criteria was met. This time was not affected by
nonclinical delays in patient transfer from the PACU to
Phase II recovery (i.e., patient transport or postsurgical
bed availability) [13].
Statistical analysis
Data are presented as mean ± standard deviation or me-
dian [25%, 75%] for continuous variables, and number
(percentage) for categorical variables. The primary end-
point was a Phase I recovery time, with secondary end-
point being the rate of PONV, and respiratory specific
events. Outcomes were compared between epochs usingFigure 1 Postanesthesia Care Unit (PACU) population in studied hospital. Leg
anesthesia care, general anesthesia with the use of laryngeal mask airway, etcthe rank sum test for continuous variables and the chi
square test for categorical variables. Postoperative events
which could prolong anesthesia recovery (e.g., respiratory
depression, PONV, hemodynamic instability, or increased
opioid analgesic administration) were characterized with
descriptive statistics. Because this study analyzed a com-
plex practice change, a series of hypothesis-generating sec-
ondary analyses were performed using multivariable
logistic regression to examine the association of the three
protocol elements with postoperative PONV and respira-
tory depression. Two-tailed P values less than 0.05 were
considered statistically significant. Statistical analyses were
performed with JMP Pro 9.0.1. (SAS Software, Inc., Cary,
NC, USA).end: *Other techniques include primary regional anesthetics, monitored
.
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General endotracheal anesthesia was administered to 2,936
and 3,137 patients during Epochs I and II, respectively.
Figure 1 shows the contribution of these patients to the
overall PACU population. Patient, surgical and anesthetic
characteristics are presented in Table 2. Changes in
anesthetic management between epochs are summarized
in Figure 2. Midazolam use decreased 57.4% to 24.0%, des-
flurane increased from 25.6% to 77.0%, isoflurane de-
creased from 50.8% to 5.7%, and triple antiemetic
prophylaxis increased from 6.5% to 50.8% in Epoch II.Table 2 Demographics, surgical and anesthetic
characteristics
Epoch I* Epoch II* P
N = 2,936 N = 3,137
Age, years 54.8 ± 16.8 54.9 ± 16.8 0.765
Male sex 1,539 (52.5) 1,689 (53.8) 0.291
ASA-PS 0.008
I 267 (9.1) 313 (10.0)
II 1,686 (57.4) 1,731 (55.2)
III 945 (32.2) 1,019 (32.5)
IV 38 (1.3) 74 (2.4)
BMI, kg/m2 29.7 ± 7.7 29.4 ± 7.6 0.234
Surgical type 0.054
General 1,070 (36.4) 1,034 (33.0)
Head/Neck 674 (23.0) 811 (25.8)
Urology 613 (20.9) 642 (20.5)
Ophthalmology 180 (6.1) 174 (5.5)
Plastics 168 (5.7) 205 (6.5)
Gastrointestinal 157 (5.4) 190 (6.1)
Orthopedics 50 (1.7) 53 (1.7)
Neurosurgical 13 (0.4) 12 (0.4)
Thoracic 11 (0.4) 16 (0.5)
Surgery duration, minutes 129 ± 97 125 ± 93.1 0.131
Intraoperative opioids, iv ME, mg 25 [10,35] 25 [15,35] <0.001
Intraoperative ketorolac 407 (13.9) 516 (16.5) 0.005
NDMR use† 1,594 (54.3) 1,848 (58.9) <0.001
Neuraxial analgesia used 88 (3.0) 119 (3.8) 0.090
Intraoperative use:
Bronchodilators 41 (1.4) 64 (2.0) 0.061
Antihypertensives 442 (15.1) 481 (15.3) 0.775
Antiarrhythmics 7 (0.2) 4 (0.1) 0.775
Vasopressors 41 (1.4) 64 (2.0) 0.061
*All patients underwent surgery/procedures under general anesthesia and few
had supplemental neuraxial analgesia. †NDMR was reversed with neostigmine
1,500 (94.1%) cases during Epoch I and 1,724 (93.3%) during Epoch II where NDMR
were used, P = 0.673. Data presented as mean ± standard deviation; number
(percentage), or median [25%,75%]. Abbreviations: ASA = American Society
of Anesthesiologists Physical Status; BMI = body mass index; iv ME = intravenous
morphine equivalents; NDMR = nondepolarizing muscle relaxantPhase I recovery time decreased by 13.9% (72 [50,
102] vs. 62 [44, 90] minutes in Epoch I and II, respect-
ively, P <0.001) (Table 3). The rates of PONV, respiratory
specific events, and administration of antihypertensive
medications declined (Table 3). Supplemental analyses
found triple antiemetic prophylaxis was associated with
PONV reduction (odds ratio 0.47, 95% CI 0.38 – 0.58,
P < 0.001). When compared to isoflurane, desflurane
was associated with a decreased rate of respiratory de-
pression (odds ratio 0.72, 95% CI 0.55-0.93, P = 0.013).
Midazolam use trended towards association to higher rates
of respiratory depression (odds ratio 1.27, 95% CI 1.00 –
1.60, P =0.050).
Discussion
The main finding is that introduction of a protocol de-
signed to reduce the rate of residual anesthetic effects
was associated with faster Phase I recovery. Specifically,
there was a reduction of oversedation as evidenced by
fewer episodes of respiratory depression, and reduction
in PONV as evidenced by fewer administrations of anti-
emetics. Secondary analyses support the notion that the
use of desflurane coupled with the avoidance of midazo-
lam was associated with reduced oversedation while an-
tiemetic prophylaxis reduced PONV, and all these effects
may have contributed to shorter PACU stay.
Desflurane has a rapid decrease in alveolar concentra-
tion after cessation, and in that regard is superior to iso-
flurane during anesthetic recovery [14-19]. Faster recovery
with desflurane over isoflurane have been observed in
morbidly obese [19] and elderly patients [17,18], a sub-
stantial fraction of the surgical population. While one con-
cern with desflurane has been airway irritability [20],
albuterol use did not differ between epochs, suggesting
there was not increases of bronchospasm. However, selec-
tion bias for sevoflurane in patients with reactive airway
disease cannot be excluded.
Because midazolam is associated with increased Phase I
recovery, the protocol narrowed its indication to patients
undergoing invasive awake procedures or experiencing not-
able anxiety. The effects of midazolam on Phase I recovery
have not been extensively studied. One prospective study of
90 elderly patients undergoing transurethral procedures
under desflurane anesthesia found midazolam prolonged
PACU discharge time and increased incidence of oxyhemo-
globin desaturations [21]. Another prospective study of 30
women undergoing laparoscopic tubal sterilization under
nitrous oxide and isoflurane found increase sedation during
Phase I recovery [22]. Another prospective study of 88 non-
obese adult ambulatory patients found that midazolam did
not affect PACU stay [14]. A supplemental analyses found
an association between respiratory depression and isoflur-
ane and a trend with midazolam suggesting that both com-
ponents can adversely impact anesthesia recovery.
Figure 2 Anesthetic management during two Epochs. Legend: *Mixed anesthetic management included patients who had multiple anesthetic.
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[23], (an association observed in this study supplemental
analyses), which contributes to faster Phase I recovery.
No patients in this study who received droperidol expe-
rienced adverse cardiac effects (dysrhythmias associated
with long QT interval, a concern that triggered FDA toTable 3 Duration of Phase I recovery from general
anesthesia and clinical outcomes
Epoch I Epoch II P
N = 2,936 N = 3,137
Phase I, minutes 72 [50,102] 62 [44,90] <0.001
PONV requiring treatment 399 (13.6) 261 (8.3) <0.001
Respiratory events* 229 (7.8) 161 (5.1) <0.001
Apnea 76 45
Hypoventilation 107 82
Oxyhemoglobin desaturation 85 63
Pain/sedation mismatch 74 48
Bronchospasm 17 (0.6) 30 (1.0) 0.107
PACU medications
Antihypertensives 266 (9.1) 188 (6.0) <0.001
Antiarrhythmic medication 7 (0.2) 3 (0.1) 0.213
Vasoactive medication 40 (1.4) 37 (1.2) 0.567
Opioids medication† 1.5 [0,10] 0 [0,9] 0.011
*The rate of respiratory events among patients administered nondepolarizing
muscle relaxant medications did not differ between patients who were
subsequently reversed with neostigmine (204 of 3,180 patients [7.7%]) or
were not reversed (14 of 218 patients [6.4%]), P = 0.597. †When excluding patients
who did not receive opioids in the PACU, the dose of opioid between epochs did
not differ (10 [5,15] iv ME mg vs. 10 [5,15] iv ME mg, P = 0.253. Data presented as
number (percentage) or median [25%, 75%]. Abbreviations: PONV = postoperative
nausea or vomiting; iv ME = intravenous morphine equivalents.issue a “black box” warning) [24]. A confounding obser-
vation is the decreased use of opioids in the PACU dur-
ing Epoch II which may be explained by the modest
increase of intraoperative opioid administration. This de-
cline in administration could have contributed to the de-
cline in PONV and respiratory depression. Another
unexplained observation was decreased use of antihyper-
tensives in Epoch II.
Limitations
This study has the inherent limitations of a retrospective
study design. Though the anesthesia protocol in Epoch II
was widely adopted, it was not universally so. Reasons for
variance may include residual practice bias and clinical
factors which could introduce a treatment bias where
anesthetic technique could be altered to account for spe-
cific patient risk factors. Although the formal practice
change was implemented on August 1, 2010, informal
adoption of protocol components may have occurred prior
to that date. Because the practice protocol was multifa-
ceted assessing the impact of individual components is dif-
ficult, but a series of hypothesis generating supplemental
analyses support the speculation that individual compo-
nents contributed to clinical improvements. However,
other factors could contribute to clinical outcomes such
as inadequate reversal of neuromuscular blocking drugs
and respiratory depression. Unaccounted management
changes could have impacted PACU efficiency; however
no changes in staffing or discharge protocol were made
during the study timeframe. Finally, though the Phase I re-
covery audit was performed retrospectively, we cannot ex-
clude a potential Hawthorne effect by healthcare staff in
Weingarten et al. BMC Anesthesiology  (2015) 15:54 Page 6 of 6anticipation of practice evaluation following protocol
implementation.
Conclusions
The introduction of an anesthetic protocol that aimed to
reduce adverse effects of anesthetics was associated with a
reduction of Phase I recovery time in adult patients under-
going general endotracheal anesthesia. These anesthetic
management changes were primarily associated with de-
creased rate of postoperative respiratory depression and
nausea and vomiting.
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